(864) 370-3297 info@glytecsystems.com

About
Solutions
Resources
Case Studies
Blog
Request a Demo

Evidence

The safety and efficacy of Glytec’s solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences around the globe. We invite you to explore them here.

Filter by Topic

Hypoglycemia Reduction Inpatient Glycemic Management SubQ Insulin IV Insulin Length of Stay Reduction Diabetic Ketoacidosis (DKA) Resolution A1C Reduction Basal Bolus Adoption Cardiovascular Patients Cost of Care Reduction Hyperglycemia Reduction Staff Education Surgical Patients Academic Medical Center Connected Diabetes Technologies ICU Outpatient Glycemic Management Readmissions Reduction Research Study Virtual Care Clinical Surveillance POC Testing Time Savings Transition IV to SubQ Competitive Comparison Continuous Glucose Monitoring Emergency Department Glucommander™ H2H® (Hospital to Home) Heart Failure Patients Patients Without Diabetes

This is a search field with an auto-suggest feature attached.

There are no suggestions because the search field is empty.

Use of Decision Support Software To Titrate Multiple Daily Injections Yielded Sustained A1c Reductions After 1 Year

Read More

Safely Converting From Sliding Scale to Basal Bolus Insulin Across an Entire Medical Center via Implementation of the eGlycemic Management System

Read More

Implementation of the eGlycemic Management System: A Medical Center Case Study

Read More

Clinical Impact of Using eGlycemic Management System for Insulin Therapy at a Large Academic Medical Center

Read More

“AUTO Study” AUtomatic Titration tO Target Subcutaneous Basal Bolus Insulin Management Using eGMS in the Non-ICU Setting

Read More

Hospitalization Costs and Clinical Outcomes in CABG Patients Treated with Intensive Insulin Therapy

Read More

Time To Target Using eGMS To Manage Inpatient Subcutaneous Insulin Basal Bolus Regimen

Read More

Glucommander Outpatient, a Cloud-Based Insulin Management Solution, Titrated Patients to Goal in 11 Days and Sustained a 2.6% Drop in HBA1C Over 6 Months

Read More

Relationship Between Glycemic Control Using eGMS and Readmission Rates in Cardiovascular Patients Hospitalized with AMI, CHF or Undergoing CABG During a System-Wide Glycemic Initiative

Read More

Does Glycemic Control Using eGMS Reduce Readmission Rates for Hospitalized Patients Undergoing CABG?

Read More

Comparison of an Electronic Glycemic Management System Versus Provider-Managed Subcutaneous Basal Bolus Insulin Therapy in the Hospital Setting

Read More

A Comparison of Glycemic Outcomes for Two Computerized Insulin Infusion Algorithms in CV Surgery Patients

Read More

Sepsis-Related Dysglycemia Can a Computerized IV Insulin Algorithm Improve Glycemic Control, Reduce Hypoglycemia and Reduce 30-Day Hospital Readmissions?

Read More

Selecting the Initial Multiplier and Target Glucose of a Computer-Guided Insulin Delivery System (Glucommander) During Treatment of Diabetic Ketoacidosis

Read More

The Frequency of Hypoglycemia in Hospitalized Patients Treated With Insulin Increases Overall Costs Associated with Hospitalization and Length of Stay

Read More

Glucommander Outpatient, a Cloud-Based Insulin Management Solution Adjusted Insulin Doses and Achieved 2.7% Drop in A1c Percentage Points

Read More

Comparison of Computer-Guided Versus Standard Insulin Infusion Regimens in Patients with Diabetic Ketoacidosis

Read More

Improved Inpatient Hypoglycemia Rates With Electronic Glycemic Management System

Read More

Blood Glucose Control Using a Computer-Guided Glucose Management System in Allogeneic Hematopoietic Cell Transplant Recipients

Read More

Use of a Computer-Based Insulin Infusion Algorithm to Treat Diabetic Ketoacidosis in the Emergency Department

Read More

eGlycemic Management System Provides Safe and Effective Glycemic Control for Stroke Patients Requiring Subcutaneous Insulin in the Hospital Setting

Read More

Finger Stickin’ Good – Improved Glycemic Control in CV Surgery Patients Provides Cost Savings Through Reduction in Point of Care Tests

Read More

Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery GLUCO-CABG Trial

Read More

eGlycemic Management System Safely Achieves Rapid and Sustained Glycemic Control in Kidney Transplant Patients and Reduces Risk of Hypoglycemia Compared to Standard Treatment Protocols

Read More

Finding the Sweet Spot in Bone Marrow Transplant Patients Computer Guided Glucose Management System in Allogeneic Hematopoietic Cell Transplant Recipients

Read More

Use of eGlycemic Management System Safely Achieves Optimal Subcutaneous Glycemic Control With Low Hypoglycemia in Patients Without Diabetes

Read More

Patients With Kidney Disease Reach Target Glucose With Low Incidence of Hypoglycemia When IV Insulin Is Managed on eGlycemic Management System Glucommander

Read More

eGlycemic Management Solution Safely Achieves Prescribed Glycemic Target with a Low Incidence of Hypoglycemia in Patients with Acute Myocardial Infarction in the Hospital

Read More

eGlycemic Management Solution Provides Safe and Effective Meal Coverage for Critical Care and Surgery Patients Managed With IV Insulin in the Hospital

Read More

eGlycemic Management Solution Safely Achieves Multiple Prescribed Glycemic Targets with Rare Hypoglycemia for Geriatric Inpatients

Read More

eGlycemic Management Solution Safely Maintains Glycemic Targets With a Low Incidence of Hypoglycemia for Non-Diabetic CV Surgical Patients in the Inpatient Setting

Read More

Use of the eGlycemic Management Solution by Glytec Achieved ADA Glycemic Targets With Low Hypoglycemia for Patients Managed on Subcutaneous Insulin Therapy

Read More

Use of the eGlycemic Management Solution by Glytec Provides Safe and Effective Glucose Control for Cardiac Surgery Patients Managed on IV Insulin Therapy

Read More

Use of the eGlycemic Management Solution by Glytec Achieves Glucose Targets for Pediatric DKA Patients Safely

Read More

Use of the eGlycemic Management Solution by Glytec to Identify, Treat and Improve Glycemic Care for CHF Patients

Read More

Use of the eGlycemic Management Solution by Glytec Provides Safe and Effective Meal Coverage for CV Patients Managed on IV Insulin Therapy

Read More

Prev 1 2 3 Next

Subscribe to our blog

Glytec is the insulin management software company for healthcare providers focused on improving the quality and cost of care. Its FDA-cleared titration software and proprietary algorithms power the only solution capable of delivering personalized diabetes treatment recommendations across the continuum of care, from hospital to home. With ongoing support from its team of doctors, nurses and technologists headquartered outside of Boston, Glytec improves outcomes and controls costs for the large population of patients requiring insulin treatment – including those with and without a diagnosis of diabetes.

Terms of Use
Legal Disclaimer
Privacy Policy
Contraindications, Warnings and Precautions

© 2023 Glytec, LLC on behalf of Aseko, Inc.

The eGlycemic Management System^® is a modularized solution for glycemic management across the care continuum that includes Glucommander^™. Glucommander^™ is a prescription-only software medical device for glycemic management intended to evaluate current as well as cumulative patient blood glucose values coupled with patient information including age, weight and height, and, based on the aggregate of these measurement parameters, whether one or many, recommend an IV dosage of insulin, glucose or saline or a subcutaneous basal and bolus insulin dosing recommendation to adjust and maintain the blood glucose level towards a configurable physician- determined target range. Glucommander^™ is indicated for use in adult and pediatric (ages 2-17 years) patients. The measurements and calculations generated are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional’s clinical judgement. No medical decision should be based solely on the recommended guidance provided by this software program.

Glucommander^™ is only available for use in the United States.

This site is only intended for use in the United States.

Aseko is a registered trademark of Aseko, Inc.